Literature DB >> 30789402

Impact of Body Temperature Abnormalities on the Implementation of Sepsis Bundles and Outcomes in Patients With Severe Sepsis: A Retrospective Sub-Analysis of the Focused Outcome Research on Emergency Care for Acute Respiratory Distress Syndrome, Sepsis and Trauma Study.

Shigeki Kushimoto1, Toshikazu Abe2,3, Hiroshi Ogura4, Atsushi Shiraishi5, Daizoh Saitoh6, Seitaro Fujishima7, Toshihiko Mayumi8, Toru Hifumi9, Yasukazu Shiino10, Taka-Aki Nakada11, Takehiko Tarui12, Yasuhiro Otomo13, Kohji Okamoto14, Yutaka Umemura4, Joji Kotani15, Yuichiro Sakamoto16, Junichi Sasaki17, Shin-Ichiro Shiraishi18, Kiyotsugu Takuma19, Ryosuke Tsuruta20, Akiyoshi Hagiwara21, Kazuma Yamakawa22, Tomohiko Masuno23, Naoshi Takeyama24, Norio Yamashita25, Hiroto Ikeda26, Masashi Ueyama27, Satoshi Fujimi22, Satoshi Gando28.   

Abstract

OBJECTIVES: To investigate the impact of body temperature on disease severity, implementation of sepsis bundles, and outcomes in severe sepsis patients.
DESIGN: Retrospective sub-analysis.
SETTING: Fifty-nine ICUs in Japan, from January 2016 to March 2017. PATIENTS: Adult patients with severe sepsis based on Sepsis-2 were enrolled and divided into three categories (body temperature < 36°C, 36-38°C, > 38°C), using the core body temperature at ICU admission.
INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS: Compliance with the bundles proposed in the Surviving Sepsis Campaign Guidelines 2012, in-hospital mortality, disposition after discharge, and the number of ICU and ventilator-free days were evaluated. Of 1,143 enrolled patients, 127, 565, and 451 were categorized as having body temperature less than 36°C, 36-38°C, and greater than 38°C, respectively. Hypothermia-body temperature less than 36°C-was observed in 11.1% of patients. Patients with hypothermia were significantly older than those with a body temperature of 36-38°C or greater than 38°C and had a lower body mass index and higher prevalence of septic shock than those with body temperature greater than 38°C. Acute Physiology and Chronic Health Evaluation II and Sequential Organ Failure Assessment scores on the day of enrollment were also significantly higher in hypothermia patients. Implementation rates of the entire 3-hour bundle and administration of broad-spectrum antibiotics significantly differed across categories; implementation rates were significantly lower in patients with body temperature less than 36°C than in those with body temperature greater than 38°C. Implementation rate of the entire 3-hour resuscitation bundle + vasopressor use + remeasured lactate significantly differed across categories, as did the in-hospital and 28-day mortality. The odds ratio for in-hospital mortality relative to the reference range of body temperature greater than 38°C was 1.760 (95% CI, 1.134-2.732) in the group with hypothermia. The proportions of ICU-free and ventilator-free days also significantly differed between categories and were significantly smaller in patients with hypothermia.
CONCLUSIONS: Hypothermia was associated with a significantly higher disease severity, mortality risk, and lower implementation of sepsis bundles.

Entities:  

Mesh:

Year:  2019        PMID: 30789402     DOI: 10.1097/CCM.0000000000003688

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  10 in total

1.  Association of triage hypothermia with in-hospital mortality among patients in the emergency department with suspected sepsis.

Authors:  Sriram Ramgopal; Christopher M Horvat; Mark D Adler
Journal:  J Crit Care       Date:  2020-07-16       Impact factor: 3.425

2.  Care bundles for improving outcomes in patients with COVID-19 or related conditions in intensive care - a rapid scoping review.

Authors:  Valerie Smith; Declan Devane; Alistair Nichol; David Roche
Journal:  Cochrane Database Syst Rev       Date:  2020-12-21

3.  Prognostic significance of body temperature in the emergency department vs the ICU in Patients with severe sepsis or septic shock: A nationwide cohort study.

Authors:  Malin Inghammar; Jonas Sunden-Cullberg
Journal:  PLoS One       Date:  2020-12-29       Impact factor: 3.240

4.  Prevalence and Prognosis of Fever Symptoms, Hypo-, and Hyperthermia in Unselected Emergency Patients.

Authors:  Alexandra Malinovska; Liliana Malinovska; Christian H Nickel; Roland Bingisser
Journal:  J Clin Med       Date:  2021-12-22       Impact factor: 4.241

5.  Fever and hypothermia represent two populations of sepsis patients and are associated with outside temperature.

Authors:  Daniel O Thomas-Rüddel; Peter Hoffmann; Daniel Schwarzkopf; Christian Scheer; Friedhelm Bach; Marcus Komann; Herwig Gerlach; Manfred Weiss; Matthias Lindner; Hendrik Rüddel; Philipp Simon; Sven-Olaf Kuhn; Reinhard Wetzker; Michael Bauer; Konrad Reinhart; Frank Bloos
Journal:  Crit Care       Date:  2021-10-21       Impact factor: 9.097

6.  Blood culture utilization practices among febrile and/or hypothermic inpatients.

Authors:  Kap Sum Foong; Satish Munigala; Stephanie Kern-Allely; David K Warren
Journal:  BMC Infect Dis       Date:  2022-10-10       Impact factor: 3.667

7.  Analysis of Spatiotemporal Urine Protein Dynamics to Identify New Biomarkers for Sepsis-Induced Acute Kidney Injury.

Authors:  Yiming Li; Junke Long; Jiaquan Chen; Jing Zhang; Yi Qin; Yanjun Zhong; Fen Liu; Zhiyong Peng
Journal:  Front Physiol       Date:  2020-03-03       Impact factor: 4.566

8.  Development and validation of a score to predict mortality in ICU patients with sepsis: a multicenter retrospective study.

Authors:  Jie Weng; Ruonan Hou; Xiaoming Zhou; Zhe Xu; Zhiliang Zhou; Peng Wang; Liang Wang; Chan Chen; Jinyu Wu; Zhiyi Wang
Journal:  J Transl Med       Date:  2021-07-29       Impact factor: 5.531

9.  The Impact of Delayed Symptomatic Treatment Implementation in the Intensive Care Unit.

Authors:  Lesley Meng; Krzysztof Laudanski; Mariana Restrepo; Ann Huffenberger; Christian Terwiesch
Journal:  Healthcare (Basel)       Date:  2021-12-25

10.  Cost-effectiveness of the TherMax blood warmer during continuous renal replacement therapy.

Authors:  Michael J Blackowicz; Max Bell; Jorge Echeverri; Kai Harenski; Marcus E Broman
Journal:  PLoS One       Date:  2022-02-03       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.